Search results
Showing 7426 to 7440 of 7687 results
Surgical correction of hallux valgus using minimal access techniques (IPG332)
This guidance has been updated and replaced by NICE interventional procedures guidance 789.
Voxelotor for treating haemolytic anaemia caused by sickle cell disease (TA981)
NICE has withdrawn this guidance. Pfizer has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that the product is being withdrawn. The recall notification is being shared with all healthcare professionals. No new people will start taking voxelotor in the UK. Healthcare professionals should discuss alternative treatment options with people currently having voxelotor.
This medtech innovation briefing (MIB) has been replaced by NICE medical technologies guidance on GaitSmart rehabilitation exercise programme for gait and mobility issues.
This medtech innovation briefing has been updated and replaced by NICE medical technologies guidance 76.
In development [GID-TA11631] Expected publication date: TBC
QbTest for the assessment of attention deficit hyperactivity disorder (ADHD) (MIB318)
This guidance has been updated and replaced by NICE diagnostics guidance 60.
Durvalumab for untreated unresectable hepatocellular carcinoma [ID4068]
Discontinued [GID-TA11041]
Atezolizumab for adjuvant treatment of renal cell carcinoma with a high risk of metastasis [ID5101]
Discontinued [GID-TA11000]
In development [GID-TA11104] Expected publication date: TBC
In development [GID-TA11163] Expected publication date: TBC
In development [GID-TA11433] Expected publication date: TBC
Regorafenib for previously treated advanced hepatocellular carcinoma (TA514)
This guidance has been updated and replaced by NICE technology appraisal guidance 555.
This guidance has been replaced by NICE technology appraisal guidance 93 [Replaced by NICE guideline CG131].
Ventripoint Medical System Plus for measuring heart volume and function (MIB310)
February 2023: The medtech innovation briefing on Ventripoint Medical System Plus for measuring heart volume and function has been withdrawn as the company have withdrawn from the process.